ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


Impact of an Anemia Clinic on Emergency Room Visits and Hospitalizations in Patients with Anemia of CKD Pre-Dialysis
(Vol 34/No. 2. On-line test expires: 04/20/2009)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Robert M. Perkins, MD
Robert M. Perkins, MD, is Director of Dialysis, Department of Medicine/Nephrology Service, Walter Reed Army Medical Center, Washington, DC.
Stephen Olson, MD
Stephen Olson, MD, is Staff Physician, Department of Medicine/Nephrology Service, Walter Reed Army Medical Service, Washington, DC.
Janice Hansen, RN
Janice Hansen, RN, is Head Nurse, Department of Medicine/Nephrology Service, Madigan Army Medical Center, Tacoma, WA.
Joseph Lee, DO
Joseph Lee, DO, is Staff Nephrologist, Kidney Specialists of Minnesota, Roseville, MN.
Kevin Stiles, MD
Kevin Stiles, MD, is Chief of Nephrology, Kaiser Permanente, Bakersfield, CA.
Christopher Lebrun, MD
Christopher Lebrun, MD, is Vice President, Nephrology Associates PC, Columbus, MS.
  OUTLINE

Aim. There is limited data regarding the impact on hospital resource use of a dedicated, nurse-managed anemia clinic in patients with pre-end stage chronic kidney disease.
Methods. A retrospective cohort study was conducted comparing patients with pre-end stage anemia of chronic kidney disease enrolled in an algorithmic anemia clinic (N = 27, treatment group) with un-enrolled patients with chronic kidney disease (N = 22, control group). The treatment group received algorithmic treatment with recombinant human erythropoietin and intravenous iron sucrose, while controls received usual care. The primary outcomes investigated were emergency room visits and hospitalizations during a 1-year period.
Results. The two groups were similar at baseline. During the first year of clinic enrollment, the mean hemoglobin values improved in the treatment group from baseline and compared with controls (11.6 ± 1.2 g/dl vs. 10.3 ± 1.0 g/dl, p < 0.05). The relative risk of an emergency room visit (RR 0.18, 95% CI 0.05-0.67, p < 0.05) and hospitalization (RR 0.20, 95% CI 0.06-0.67, p < 0.05) were reduced in the treatment group versus the control group. The average length of hospital stay was also reduced (6.8 days vs. 9.5 days, p = 0.05).
Conclusion. Enrollment in a dedicated nurse-managed anemia clinic is significantly associated with reduced emergency room visits and hospitalizations in patients with pre-end stage CKD. These associative findings justify future prospective analyses to establish causality.

  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.4 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses’ Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910; and the Kansas State Board of Nursing, Provider No. LT0148-0738. This offering is accepted for RN and LPN relicensure in Kansas

  EDUCATIONAL OBJECTIVES

Goal:
To describe the effects of a nurse-managed, algorithmic treatment plan for anemia on emergency room visits and hospitalizations in patients with chronic kidney disease.

Objectives:
1. Summarize the effects of a nurse-managed, algorithmic treatment of patients with anemia and CKD.
2. Relate the limitations of a study done on patients with anemia and CKD.
3. Generate ideas for future studies on the management of anemia in patients with CKD.


AUTHOR DISCLOSURE STATEMENT
Robert M. Perkins has no conflicts of interest to disclose.
Stephen Olson has no conflicts of interest to disclose.
Janice Hansen has no conflicts of interest to disclose.
Joseph Lee has no conflicts of interest to disclose.
Kevin Stiles has no conflicts of interest to disclose.
Christopher Lebrun has no conflicts of interest to disclose.

 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.